Literature DB >> 8407726

Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction.

K Yorimitsu1, T Saito, T Toyozaki, T Ishide, N Ohnuma, Y Inagaki.   

Abstract

Immunohistochemical localization of plasminogen activator inhibitor-1 (PAI-1) was studied using the streptavidin-biotin method in human atherosclerotic coronary arteries. The patients (one male and two females), whose ages ranged from 61 to 78 years, died of anteroseptal acute myocardial infarction without having received any thrombolytic therapy. PAI-1 immunoreactivities (IRs) were mainly detected in the endothelial cells, smooth muscle cells, and collagen fibers of the coronary arterial intima and not in thrombi. Remarkable immunohistochemical staining was seen in intimal collagen fibers. In one patient, intimal PAI-1 IRs partly bordered a thrombus and surrounded a large atheroma rich in cholesterol crystals. Our results suggest that PAI-1 is present in both cellular and extracellular components of human coronary atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407726     DOI: 10.1007/bf01744801

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  16 in total

Review 1.  The plasminogen-plasmin system.

Authors:  J Henkin; P Marcotte; H C Yang
Journal:  Prog Cardiovasc Dis       Date:  1991 Sep-Oct       Impact factor: 8.194

2.  Distribution of plasminogen activator inhibitor (PAI-1) in tissues.

Authors:  A J Simpson; N A Booth; N R Moore; B Bennett
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

Review 3.  Plasminogen activator inhibitors.

Authors:  E D Sprengers; C Kluft
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

4.  Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment.

Authors:  B S Knudsen; R L Nachman
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

5.  Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke.

Authors:  F Andreotti; G J Davies; D R Hackett; M I Khan; A C De Bart; V R Aber; A Maseri; C Kluft
Journal:  Am J Cardiol       Date:  1988-09-15       Impact factor: 2.778

6.  The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).

Authors:  J M Edelberg; C F Reilly; S V Pizzo
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

7.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

Authors:  J Schneiderman; M S Sawdey; M R Keeton; G M Bordin; E F Bernstein; R B Dilley; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section.

Authors:  T Horie; M Sekiguchi; K Hirosawa
Journal:  Br Heart J       Date:  1978-02

10.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

Authors:  A Hamsten; B Wiman; U de Faire; M Blombäck
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

View more
  1 in total

Review 1.  Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.

Authors:  Garry X Shen
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.